No Data
Sino Biological Inc.: 2025 First Quarter Report
Yiqiao Shenzhou: 2024 Annual Report
Yiqiao Shenzhou: 2024 Annual Report Summary
Yiqiao Shenzhou (301047.SZ): The net income for 2024 is 0.122 billion yuan, and a dividend of 10 yuan per share is proposed.
Globe Network reported on April 18 that Yiqiao Shenzhou (301047.SZ) released its annual report for 2024. The company achieved revenue of 0.614 billion yuan in 2024, a year-on-year decrease of 5.06%. The net income attributable to shareholders of the listed company was 0.122 billion yuan, a decrease of 53.13% year-on-year; the net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 36.541 million yuan, a decrease of 78.27% year-on-year; the basic EPS was 0.9530 yuan; a cash dividend of 10.00 yuan (including tax) is proposed to be distributed to all shareholders for every 10 shares.
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
The Recent 5.3% Gain Must Have Brightened President Liangzhi Xie's Week, Sino Biological,Inc.'s (SZSE:301047) Most Bullish Insider
Are Poor Financial Prospects Dragging Down Sino Biological,Inc. (SZSE:301047 Stock?
